DNMT3B and breast cancer: In the present study, we analyzed breast cancer cell lines for differential expression of regulatory miRs to determine if loss of miR-mediated post-transcriptional regulation of DNMT3b represents the molecular mechanism that governs the overexpression of DNMT3b which drives the hypermethylation defect in breast cancer.